| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |